Sažetak
Apstrakt
Uvod/Cilj. Razvoj inflamatornih promena i ožiljavanja i gubitak morfoloških struktura intersticijuma zauzimaju značajno mesto u patogenezi primarnih glomerulonefritisa, što utiče na nastanak, tok i prognozu ove bolesti. Cilj istraživanja bio je da se ispita uticaj promena u intersticijumu na prognozu primarnih glomerulonefitisa. Metode. Ispitivanjem je bilo obuhvaćeno 216 bolesnika sa različitim tipovima primarnih glomerulonefritisa lečenih na Klinici za nefrologiju i kliničku imunologiju Kliničkog centra Vojvodine koji su praćeni prosečno 77,5 meseci. Nakon utvrđivanja patohistološke dijagnoze tipa glomerulonefritisa, kvantifikovane su promene u intersticijumu bubrega. Određivana je numerička gustina u jedinici zapremine tkiva i struktura infiltrata korišćenjem Weibel-ovog sistema (M42) inkorporisanog u svetlosni mikroskop. Rutinske analize rađene su standardnom laboratorijskom procedurom. Rezultati: Tokom ispitivanog perioda najveća numerička gustina infiltrata verifikovana je kod esktrakapilarnog glomerulonefritisa (147 869 × mm-3), nešto manja kod membranoproliferativnog glomerulonefritisa (116 800 × mm-3) i fokalnosegmentne glomeruloskleroze (96 147 × mm-3), a najmanja kod glomerulonefritisa sa minimalnim promenama (11 416 × mm-3). Kod svih tipova glomerulonefritisa, osim glomerulonefritisa sa minimalnim promenama, ustanovljena je značajno (p < 0,0005) veća numerička gustina i zastupljenost ćelija infiltrata u odnosu na kontrolnu grupu. Upoređujući numeričku gustinu infiltrata svih ćelija sa parametrima bubrežne funkcije, utvrđena je značajna (p < 0,01) povezanost ovih pojava. Radi boljeg uvida u brzinu progresije bubrežne insuficijencije postavljenjem numeričke granice gustine infiltrata < 100 000 / > 100 000 ćelija/mm3 nezavisno od tipa glomerulonefritisa, ustanovljen je prognostički prediktor na osnovu kojeg su bolesnici sa manjom infiltracijom intersticijuma imali značajno (p < 0,005) sporiju progresiju bubrežne insuficijencije. Zaključak. Gustina infiltrata u intersticijumu kod primarnih glomerulonefritisa je važan, rani prognostički prediktor progresije bubrežne insuficijencije.
Ključne reči
Array
Array
Array
Array
Reference
REFERENCES
Platt JL, Grant BW, Eddy AA, Michael AF. Immune cell popu-lations in cutaneous delayed-type hypersensitivity. J Exp Med 1983; 158(4): 1227–42.
Hancock WW, Becker GJ, Atkins RC. A comparison of fixatives and immunohistochemical technics for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol 1982; 78(6): 825–31.
Hooke DH, Gee DC, Atkins RC. Leukocyte analysis using mo-noclonal antibodies in human glomerulonephritis. Kidney Int 1987; 31(4): 964–72.
Stachura I, Si L, Madan E, Whiteside T. Mononuclear cell subsets in human renal disease. Enumeration in tissue sections with monoclonal antibodies. Clin Immunol Immunopathol 1984; 30(3): 362–73.
Lan HY, Paterson DJ, Atkins RC. Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 1991; 40(3): 425–33.
Hu SY, Jia XY, Li JN, Zheng X, Ao J, Liu G, Cui Z, Zhao MH. T cell infiltration is associated with kidney injury in patients with anti-glomerular basement membrane disease. Sci China Life Sci 2016; 59(12): 1282–9.
Burton CJ, Walls J. Harris KP. Characterisation of the serum factor that stimulates human cortical epithelial cells to produce fibronectin (FN) and PDGF (abstract). J Am Soc Nephrol 1995: 6: 1010.
Nikolic-Paterson DJ, Wang S, Lan HY. Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int 2014; 4(1): 34–8.
Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ. Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis. Am J Physiol Renal Physiol 2013; 304(8): F1043–53.
Bob RF, Herman D, Gluhovschi G, Petrica L, Bozdog G, Velciov S, et al. Is The histological scoring system useful in assessing pa-tients with glomerulonephritis?. BANTAO J 2011; 9(2): 72–6.
Bohle A, Christ H, Grund KE, Mackensen S. The role of the in-terstitium of the renal cortex in renal disease. Contrib Nephrol 1979; 16: 109–14.
Chatenoud L, Bach MA. Abnormalities of T-cell subsets in glo-merulonephritis and systemic lupus erythematosus. Kidney Int 1981; 20(2): 267–74.
Ihm CG. Hypertension in Chronic Glomerulonephritis. Elec-trolyte Blood Press 2015; 13(2): 41–5.
Abercrombie M. Estimation of nuclear population from micro-tome sections. Anat Rec 1946; 94: 239–47
Weibel ER, Gomez DM. A principle for counting tissue struc-tures on random sections. J Appl Physiol 1962; 17: 343–8.
Habib R. Classification of glomerulonephritis based on mor-phology. Perspect Nephrol Hypertens 1973; 1 Pt 1: 17–41.
Churg J, Duffy JL. Classification of glomerulonephritis based on morphology. Perspect Nephrol Hypertens 1973; 1 Pt 1: 43–61.
Weibel ER. Stereology: A bridge between morphology and physiology. Acta Stereol 1982; 1: 23–31.
Alexopoulos E, Seron D, Hartley RB, Nolasco F, Cameron JS. The role of interstitial infiltrates in IgA nephropathy: a study with monoclonal antibodies. Nephrol Dial Transplant 1989; 4(3): 187–95.
Schena FP, Mastrolitti G, Jirillo E, Munno I, Pellegrino N, Fracasso AR, et al. Increased production of interleukin-2 and IL-2 re-ceptor in primary IgA nephropathy. Kidney Int 1989; 35(3): 875–9.
Serón D, Alexopoulos E, Raftery MJ, Hartley B, Cameron JS. Number of interstitial capillary cross-sections assessed by monoclonal antibodies: Relation to interstitial damage. Nephrol Dial Transplant 1990; 5(10): 889–93.
Li HL, Hancock WW, Hooke DH, Dowling JP, Atkins RC. Mo-nonuclear cell activation and decreased renal function in IgA nephropathy with crescents. Kidney Int 1990; 37(6): 1552–6.
Danilewicz M, Wagrowska-Danilewicz M. Idiopathic membranous glomerulonephritis: a quantitative study of glomerular and in-terstitial lesions. Pol J Pathol 1995; 46(3): 173–7.
Hao W, Rovin BH, Friedman A. Mathematical model of renal interstitial fibrosis. Proc Natl Acad Sci U S A 2014; 111(39): 14193–8.
Lin TJ, Yang SS, Hua KF, Tsai YL, Lin SH, Ka SM. SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway. Free Radic Biol Med 2016; 99: 21–24.
Truong LD, Trostel J, McMahan R, Chen JF, Garcia GE. Macro-phage A2A Adenosine Receptors Are Essential to Protect from Progressive Kidney Injury. Am J Pathol 2016; 186(10): 2601–13.
Bob F, Gluhovschi G, Herman D, Petrica L, Bozdog G, Gluhovschi C, et al. Immunohistochemical study of tubular epithelial cells and vascular endothelial cells in glomerulonephritis. Ren Fail 2014; 36(8): 1208–14.